Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Change in Cash (2020 - 2025)

Historic Change in Cash for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $268000.0.

  • Agilon Health's Change in Cash fell 9928.45% to $268000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year increase of 17229.02%. This contributed to the annual value of $79.5 million for FY2024, which is 12021.88% up from last year.
  • As of Q3 2025, Agilon Health's Change in Cash stood at $268000.0, which was down 9928.45% from $32.8 million recorded in Q2 2025.
  • In the past 5 years, Agilon Health's Change in Cash ranged from a high of $1.0 billion in Q2 2021 and a low of -$352.6 million during Q2 2022
  • For the 5-year period, Agilon Health's Change in Cash averaged around $1.7 million, with its median value being -$22.6 million (2023).
  • As far as peak fluctuations go, Agilon Health's Change in Cash skyrocketed by 1285800.68% in 2021, and later crashed by 140862.35% in 2025.
  • Agilon Health's Change in Cash (Quarter) stood at -$41.1 million in 2021, then tumbled by 38.25% to -$56.8 million in 2022, then decreased by 13.05% to -$64.2 million in 2023, then skyrocketed by 162.4% to $40.1 million in 2024, then crashed by 99.33% to $268000.0 in 2025.
  • Its Change in Cash was $268000.0 in Q3 2025, compared to $32.8 million in Q2 2025 and -$55.2 million in Q1 2025.